Earum Pharmaceuticals Limited
BSE: EARUM
Prev Close
1.93
Open Price
1.75
Volume
247,280
Today Low / High
1.75 / 1.75
52 WK Low / High
1.75 / 1.75
Range
2 - 2
The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 1.75, reflecting a change of -0.09 (-4.8913%). The expected target range on the BSE is 2 - 2. The stock is showing a downward trend on the BSE. This could indicate a potential risk for investors who are considering buying at this moment.
Earum Pharmaceuticals Limited Graph
Earum Pharmaceuticals Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Earum Pharmaceuticals Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 1.75, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
Scenario | Price | Target | Range |
---|---|---|---|
Bullish Scenario | 1.75 | 1.77 | 1.59 - 1.94 |
1.79 | 1.43 - 2.14 | ||
1.80 | 1.26 - 2.34 | ||
Bearish Scenario | 1.75 | 1.73 | 1.56 - 1.91 |
1.72 | 1.37 - 2.06 | ||
1.70 | 1.19 - 2.21 |
Overview of Earum Pharmaceuticals Limited
ISIN
INE060601023
Industry
Medical - Instruments & Supplies
Vol.Avg
0
Market Cap
0
Last Dividend
0
Official Website
IPO Date
DCF Diff
3.24
DCF
-1
Financial Ratios Every Investor Needs
Annual Financial Income Report
Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
---|---|---|---|---|---|---|---|---|---|---|---|
2023-03-31 | 14.09 Cr | 12.47 Cr | 1.62 Cr | 0.1149 | 0.00 Cr | 0.00 Cr | 0.82 Cr | 1.98 Cr | 0.27 | 0.93 Cr | 0.1406 |
2022-03-31 | 21.04 Cr | 25.22 Cr | -4.18 Cr | -0.1987 | 0.00 Cr | 0.00 Cr | -4.54 Cr | 2.22 Cr | 0.30 | -4.42 Cr | 0.1057 |
2021-03-31 | 41.08 Cr | 46.70 Cr | -5.62 Cr | -0.1368 | 0.00 Cr | 0.00 Cr | -7.86 Cr | 0.09 Cr | 0.01 | -7.73 Cr | 0.0021 |
2020-03-31 | 55.11 Cr | 51.07 Cr | 4.04 Cr | 0.0733 | 0.00 Cr | 0.00 Cr | 1.14 Cr | 1.82 Cr | 0.25 | 1.24 Cr | 0.0329 |
2019-03-31 | 50.70 Cr | 46.56 Cr | 4.14 Cr | 0.0816 | 0.00 Cr | 0.00 Cr | 3.27 Cr | 1.66 Cr | 0.23 | 3.31 Cr | 0.0328 |
Annual Financials Balance Sheet
Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2023-03-31 | 0.03 Cr | 28.58 Cr | 9.88 Cr | 18.7065 Cr | 8.74 Cr | 8.71 Cr | 16.74 Cr | 0.47 Cr | 1.60 Cr | 0.00 Cr | 0.00 Cr | 9.8663 Cr |
2022-03-31 | 0.05 Cr | 28.79 Cr | 12.07 Cr | 16.7253 Cr | 8.74 Cr | 8.69 Cr | 12.54 Cr | 0.58 Cr | 1.02 Cr | 0.00 Cr | 0.00 Cr | 12.0584 Cr |
2021-03-31 | 0.06 Cr | 27.87 Cr | 13.37 Cr | 14.5012 Cr | 11.33 Cr | 11.27 Cr | 15.76 Cr | 0.76 Cr | 0.38 Cr | 0.00 Cr | 0.00 Cr | 10.9787 Cr |
2020-03-31 | 0.03 Cr | 36.16 Cr | 21.74 Cr | 14.4129 Cr | 9.28 Cr | 9.26 Cr | 14.05 Cr | 0.79 Cr | 0.63 Cr | 0.00 Cr | 3.03 Cr | 20.3641 Cr |
2019-03-31 | 0.16 Cr | 23.25 Cr | 17.31 Cr | 5.9449 Cr | 9.58 Cr | 9.42 Cr | 10.93 Cr | 0.47 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 14.9413 Cr |
Annual Financials Cash Flow Statement
Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
---|---|---|---|---|---|---|---|---|---|---|---|
2023-03-31 | -0.0279 Cr | 0.0000 Cr | 0.0000 Cr | -0.0279 Cr | -0.0278 Cr | 0.0252 Cr | 0.0000 Cr | 1.9812 Cr | 0.0000 Cr | 0.0000 Cr | -0.8844 Cr |
2022-03-31 | 2.6125 Cr | 0.0621 Cr | -2.5920 Cr | 2.6125 Cr | -0.0055 Cr | 0.0530 Cr | 0.0000 Cr | 2.2241 Cr | 0.0000 Cr | 0.0000 Cr | 3.2146 Cr |
2021-03-31 | -5.8017 Cr | 2.9394 Cr | 2.8954 Cr | -5.8893 Cr | 0.0332 Cr | 0.0585 Cr | -0.0876 Cr | 0.0882 Cr | 0.0000 Cr | 0.0000 Cr | -2.0694 Cr |
2020-03-31 | -3.4464 Cr | -3.4476 Cr | 6.7584 Cr | -3.8670 Cr | -0.1357 Cr | 0.0254 Cr | -0.4206 Cr | 1.8152 Cr | 0.0000 Cr | 0.0000 Cr | -2.4603 Cr |
2019-03-31 | -0.4798 Cr | -0.3181 Cr | 0.9366 Cr | -0.7979 Cr | 0.1387 Cr | 0.1610 Cr | -0.3181 Cr | 1.6614 Cr | 0.0000 Cr | 0.0000 Cr | -2.6420 Cr |
Quarterly Financial Income Report
Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
---|---|---|---|---|---|---|---|---|---|
2023-12-31 | 0.40 Cr | 0.33 Cr | 0.07 Cr | 0.1688 | 0.04 Cr | 0.04 Cr | 0.00 | 0.06 Cr | 0.0909 |
2023-09-30 | 0.43 Cr | 0.96 Cr | -0.53 Cr | -1.2345 | -0.97 Cr | -0.87 Cr | -0.04 | -0.95 Cr | -2.0324 |
2023-06-30 | 1.71 Cr | 2.34 Cr | -0.62 Cr | -0.3637 | -0.68 Cr | -0.28 Cr | -0.01 | -0.66 Cr | -0.1636 |
2023-03-31 | 1.53 Cr | -0.42 Cr | 1.95 Cr | 1.2722 | 1.17 Cr | 0.26 Cr | 0.04 | 1.20 Cr | 0.1705 |
2022-12-31 | 1.17 Cr | 1.03 Cr | 0.14 Cr | 0.1163 | 0.11 Cr | 1.37 Cr | 0.19 | 0.14 Cr | 1.1735 |
Quarterly Financials Balance Sheet
Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
---|---|---|---|---|---|---|---|---|---|
2023-12-31 | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
2023-09-30 | 0.02 Cr | 0.00 Cr | 0.02 Cr | 11.80 Cr | 12.05 Cr | 59.98 Cr | 0.44 Cr | 60.51 Cr | 5.87 Cr |
2023-06-30 | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
2023-03-31 | 0.03 Cr | 0.00 Cr | 0.03 Cr | 8.39 Cr | 16.74 Cr | 28.11 Cr | 0.47 Cr | 28.58 Cr | 9.88 Cr |
2022-12-31 | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
Quarterly Financials Cash Flow Statement
Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
---|---|---|---|---|---|---|---|---|---|
2023-12-31 | 0.04 Cr | 0.04 Cr | 0.00 Cr | 0.00 Cr | 0.04 Cr | 0.06 Cr | 0.02 Cr | 0.00 Cr | 0.04 Cr |
2023-09-30 | -0.87 Cr | -0.87 Cr | 0.00 Cr | 0.00 Cr | -0.87 Cr | 0.02 Cr | 0.89 Cr | 0.00 Cr | -0.87 Cr |
2023-06-30 | -0.28 Cr | -0.28 Cr | 0.00 Cr | 0.00 Cr | -0.31 Cr | -0.28 Cr | 0.03 Cr | 0.00 Cr | -0.28 Cr |
2023-03-31 | 0.26 Cr | 0.26 Cr | 0.00 Cr | 0.00 Cr | 0.26 Cr | 0.03 Cr | -0.24 Cr | 0.00 Cr | 0.26 Cr |
2022-12-31 | 1.37 Cr | 1.37 Cr | 0.00 Cr | 0.00 Cr | 1.07 Cr | 1.37 Cr | 0.30 Cr | 0.00 Cr | 1.37 Cr |
Splits History
Date | Label | Split Ratio |
---|---|---|
No split history data available. |
Similar Stocks: Medical - Instruments & Supplies
Company Name | Symbol | Price | Market Cap | Volume |
---|---|---|---|---|
Poly Medicure Limited | POLYMED | ₹2,070.60 | ₹209,805,615,600.00 | ₹724,200.00 |
Dr. Agarwal's Health Care Limited | AGARWALEYE | ₹455.65 | ₹144,057,556,734.00 | ₹88,795.00 |
Shaily Engineering Plastics Limited | SHAILY | ₹2,103.40 | ₹96,661,957,340.00 | ₹463,986.00 |
Key Executives
No executive data available.
FAQs about Earum Pharmaceuticals Limited
The CEO is Tilva Manthan Rameshbhai.
The current price is ₹1.75.
The range is ₹1.75-1.75.
The P/E ratio is 6.45.
The company operates in the Healthcare sector.
Overview of Earum Pharmaceuticals Limited (ISIN: INE060601023) is a leading Medical - Instruments & Supplies in India. With a market capitalization of ₹0.00 crores and an average daily volume of 0 shares, it operates in the Medical - Instruments & Supplies. The company last declared a dividend of ₹0.